Cargando…

Development of (18)F-Labeled Radiotracers for PET Imaging of the Adenosine A(2A) Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation

The adenosine A(2A) receptor (A(2A)R) represents a potential therapeutic target for neurodegenerative diseases. Aiming at the development of a positron emission tomography (PET) radiotracer to monitor changes of receptor density and/or occupancy during the A(2A)R-tailored therapy, we designed a libr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Thu Hang, Schröder, Susann, Toussaint, Magali, Dukić-Stefanović, Sladjana, Kranz, Mathias, Ludwig, Friedrich-Alexander, Fischer, Steffen, Steinbach, Jörg, Deuther-Conrad, Winnie, Brust, Peter, Moldovan, Rareş-Petru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956753/ https://www.ncbi.nlm.nih.gov/pubmed/33669003 http://dx.doi.org/10.3390/ijms22052285

Ejemplares similares

Synthesis and Biological Evaluation of a Novel (18)F-Labeled Radiotracer for PET Imaging of the Adenosine A(2A) Receptor
por: Lai, Thu Hang, et al.
Publicado: (2021)

PET Imaging of the Adenosine A(2A) Receptor in the Rotenone-Based Mouse Model of Parkinson’s Disease with [(18)F]FESCH Synthesized by a Simplified Two-Step One-Pot Radiolabeling Strategy
por: Schröder, Susann, et al.
Publicado: (2020)

Improved in vivo PET imaging of the adenosine A(2A) receptor in the brain using [(18)F]FLUDA, a deuterated radiotracer with high metabolic stability
por: Lai, Thu Hang, et al.
Publicado: (2021)

Development of a Radiofluorinated Adenosine A(2B) Receptor Antagonist as Potential Ligand for PET Imaging
por: Lindemann, Marcel, et al.
Publicado: (2020)

Non-Invasive Assessment of Locally Overexpressed Human Adenosine 2A Receptors in the Heart of Transgenic Mice
por: Gündel, Daniel, et al.
Publicado: (2022)

Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine-Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography
por: Ritawidya, Rien, et al.
Publicado: (2019)

Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [(18)F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain
por: Clauß, Oliver, et al.
Publicado: (2022)

Quantitation of the A(2A) Adenosine Receptor Density in the Striatum of Mice and Pigs with [(18)F]FLUDA by Positron Emission Tomography
por: Gündel, Daniel, et al.
Publicado: (2022)

Development of cannabinoid receptor (CB 2 R) ligands for application in PET studies - where to attach the radiolabel?
por: Günther, Robert, et al.
Publicado: (2014)

Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging
por: Sadeghzadeh, Masoud, et al.
Publicado: (2020)

Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A(2B) Receptor Binding Affinity
por: Lindemann, Marcel, et al.
Publicado: (2021)

Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant (18)F-Labelled σ(2) Receptor Ligand
por: Moldovan, Rareş-Petru, et al.
Publicado: (2021)

Development of [(18)F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain
por: Teodoro, Rodrigo, et al.
Publicado: (2021)

Synthesis, (18)F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography
por: Schröder, Susann, et al.
Publicado: (2015)

Preclinical Incorporation Dosimetry of [(18)F]FACH—A Novel (18)F-Labeled MCT1/MCT4 Lactate Transporter Inhibitor for Imaging Cancer Metabolism with PET
por: Sattler, Bernhard, et al.
Publicado: (2020)

Preclinical Evaluation of [(18)F]FACH in Healthy Mice and Piglets: An (18)F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET
por: Gündel, Daniel, et al.
Publicado: (2021)

Synthesis and Preliminary Biological Evaluation of Indol-3-yl-oxoacetamides as Potent Cannabinoid Receptor Type 2 Ligands
por: Moldovan, Rareş-Petru, et al.
Publicado: (2017)

Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain
por: Liu, Jianrong, et al.
Publicado: (2016)

Synthesis, Structure–Activity Relationships, Radiofluorination, and Biological Evaluation of [(18)F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET
por: Teodoro, Rodrigo, et al.
Publicado: (2023)

Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
por: Mitrach, Franziska, et al.
Publicado: (2022)

A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013)

Radiofluorination and biological evaluation of N-aryl-oxadiazolyl-propionamides as potential radioligands for PET imaging of cannabinoid CB(2) receptors
por: Teodoro, Rodrigo, et al.
Publicado: (2013)

Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(−)-[(18)F]Fluspidine in Glioblastoma
por: Toussaint, Magali, et al.
Publicado: (2020)

Investigation of an (18)F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A
por: Schröder, Susann, et al.
Publicado: (2018)

Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012
por: Schröder, Susann, et al.
Publicado: (2016)

Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation
por: Rühl, Thomas, et al.
Publicado: (2012)

Development of Fluorinated Non-Peptidic Ghrelin Receptor Ligands for Potential Use in Molecular Imaging
por: Moldovan, Rareş-Petru, et al.
Publicado: (2017)

Radiosynthesis and Radiotracer Properties of a 7-(2-[(18)F]Fluoroethoxy)-6-methoxypyrrolidinylquinazoline for Imaging of Phosphodiesterase 10A with PET
por: Funke, Uta, et al.
Publicado: (2012)

Radiolabeled cyclic RGD peptides as radiotracers for tumor imaging
por: Shi, Jiyun, et al.
Publicado: (2016)

Radiosynthesis and Preclinical Evaluation of an (18)F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)
por: Wenzel, Barbara, et al.
Publicado: (2022)

Novel Radioiodinated and Radiofluorinated Analogues of FT-2102 for SPECT or PET Imaging of mIDH1 Mutant Tumours
por: Weber, Valérie, et al.
Publicado: (2022)

Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT
por: Zhou, Yang, et al.
Publicado: (2011)

Radiolabeled Chalcone Derivatives as Potential Radiotracers for β-Amyloid Plaques Imaging
por: Capponi, Pier Cesare, et al.
Publicado: (2023)

Newly Synthesized Fluorinated Cinnamylpiperazines Possessing Low In Vitro MAO-B Binding
por: I. Jevtić, Ivana, et al.
Publicado: (2020)

Recent advances in radiotracers targeting norepinephrine transporter: structural development and radiolabeling improvements
por: Chen, Xinyu, et al.
Publicado: (2020)

One-step radiosynthesis of the MCTs imaging agent [(18)F]FACH by aliphatic (18)F-labelling of a methylsulfonate precursor containing an unprotected carboxylic acid group
por: Sadeghzadeh, Masoud, et al.
Publicado: (2019)

Exploring the Metabolism of (+)-[(18)F]Flubatine In Vitro and In Vivo: LC-MS/MS Aided Identification of Radiometabolites in a Clinical PET Study †
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2018)

Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ(1) Receptors in the Brain
por: Holl, Katharina, et al.
Publicado: (2014)

Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine—A New Tracer in Clinical Translation for Imaging of σ(1) Receptors
por: Kranz, Mathias, et al.
Publicado: (2016)

Radiation dosimetry of the α(4)β(2) nicotinic receptor ligand (+)-[(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results
por: Kranz, Mathias, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_mho2jorjmobenp586sr4leut34